Olema shareholders elect three Class II directors, approve say-on-pay, ratify EY

Olema Pharmaceuticals, Inc.

Cynthia Butitta: 44,675,129 for, 11,733,848 withheld; Cyrus Harmon: 43,838,514 for, 12,570,463 withheld; Graham Walmsley: 44,120,432 for, 12,288,545 withheld.
Advisory vote on executive compensation: 54,057,177 for, 2,297,482 against, 54,317 abstain; broker non-votes 6,361,695.
Ratification of Ernst & Young as auditor: 62,732,079 for, 24,064 against, 14,528 abstain; no broker non-votes.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.